A new blood test can detect lung cancer in real time, enabling earlier diagnosis, quicker treatment, reduced delays, and ...

There are roughly 225,000 new cases of lung cancer every year in the United States. Early diagnosis and treatment play a large role in improving outcomes. A recently developed nasal swab test could ...

SAN ANTONIO, Texas--(BUSINESS WIRE)--A new economic study found that adding CyPath® Lung, bioAffinity Technologies’ noninvasive test for detection of early-stage lung cancer, to the standard of care ...

Researchers have developed a groundbreaking blood test using Fourier Transform Infrared (FT-IR) microspectroscopy to detect a ...

A team of UK researchers has developed a pioneering blood test that could enable doctors to detect and monitor lung cancer in ...

UK researchers have developed a blood test capable of detecting and monitoring lung cancer in real time using infrared ...

Small cell lung cancer (SCLC) is a fast-growing cancer that develops in cells within the lung. A range of medical tests and procedures are available to help doctors diagnose SCLC and create an ...

An X-ray can help healthcare professionals find non-small cell lung cancer tumors and gain a deeper understanding of them. The healthcare team will also need other imaging and tests for a complete ...

Thermo Fisher Scientific has launched a new diagnostic test to help physicians better detect and manage lung transplant rejection. Dubbed the Molecular Microscope Diagnostic System for Lung, the test ...

The MarketWatch News Department was not involved in the creation of this content. American Lung Association launches campaign to address barriers to lung cancer screening and care CHICAGO, Sept. 24, ...

Peer-Reviewed Study: bioAffinity Technologies’ CyPath® Lung Test Shows Potential Significant Healthcare Savings by Reducing Unnecessary Follow-Up, Medical Complications and Overdiagnosis Study by BAMC ...